Therefore, once the LEMS is diagnosed, it is necessary to screen for malignant neoplasm, especially lung cancer (for example, using chest CT or tumor markers: neuron-specific enolase and progastrin-releasing peptide, even bronchoscopy) every 6 months for two consecutive years [11]. This evidence concerns the gene ENO2 and lung carcinoma.